Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
  • Subscribe
Submit An Article

Latest Articles

  • Monash IVF joins M&A arms race with entry into Perth IVF market via acquisition
    Monash IVF joins M&A arms race with entry into Perth IVF market via acquisition
    • News

  • In an age where celebs own tequila brands, this one owns a hangover cure
    In an age where celebs own tequila brands, this one owns a hangover cure
    • News

  • Markets continue to recover, commodities lead the charge overnight
    Markets continue to recover, commodities lead the charge overnight
    • Market Update

  • Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap
    Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap
    • Opinion

  • Crowd Media enters Silicon Valley partnership for interactive NFT collection
    Crowd Media enters Silicon Valley partnership for interactive NFT collection
    • News

  • MPower acquires Lakeland in $8m deal
    MPower acquires Lakeland in $8m deal
    • News

  • US market falls on Tech and Discretionary as Oil surges
    US market falls on Tech and Discretionary as Oil surges
    • Market Update

  • SportsHero launches eSports predictor in China to gamify eSports gambling
    SportsHero launches eSports predictor in China to gamify eSports gambling
    • News

  • This company is offering DNA tests for the whole family, including the dog!
    This company is offering DNA tests for the whole family, including the dog!
    • News

  • Regis Healthcare to claim back $14m spent on aged care COVID outbreaks
    Regis Healthcare to claim back $14m spent on aged care COVID outbreaks
    • News

Spray On Skin available to over 200,000 more US healthcare providers following purchasing agreement

  • In News
  • March 3, 2022
  • Samantha Freidin
Spray On Skin available to over 200,000 more US healthcare providers following purchasing agreement

4,440 US hospitals and health systems will soon have access to Avita Medical’s (ASX: AVH) proprietary RECELL System thanks to a purchasing agreement signed with Premier, a leading healthcare improvement company in the US. 

Premier’s mission is to enable optimal patient care at reasonable cost within their alliance of 4,400 US hospitals and 225,000 other healthcare providers. To do this, Premier uses integrated data and analytics and consults on things like supply chain logistics and facilitation of collaborations. 

Avita’s proprietary RECELL System, invented by Professor Fiona Wood AM allows for treatment of severe burns and wounds where there is serious unmet need. Burns can leave scars that can be debilitating both functionally and aesthetically. RECELL is a regenerative medicine approach that works by using the patient’s own skin in a special suspension (called Spray On Skin) which is then sprayed onto the skin to regenerate a natural, healthy epidermis. 

The patented RECELL System is FDA approved as of September 2018 with its primary indication as acute thermal burns. The System is designed for use at the point-of-care and has been clinically validated in clinical trials and within the real world with over 10,000 patients globally benefitting from the technology. February 2022 saw the FDA approve Avita’s premarket approval application for their RECELL Autologous Cell Harvesting Device, an add-on to enhance the current System for increased efficiency. 

The new purchasing agreement between Premier and Avita will allow Premier members access to the RECELL System at a special pre-negotiated price. 

Avita’s CEO, Dr. Mike Perry welcomed this agreement, saying: “When someone experiences a severe burn injury, time matters, and that is why this agreement with Premier is so important- it will help ensure that patients in need of treatment are able to efficiently and effectively access the RECELL System without delay.”

“As a leading GPO, Premier is a trusted partner among their alliance of members and Avita Medical is committed to building on that trust by providing quality products to help ensure the best patient care possible. This agreement represents a major milestone for Avita Medical as it puts our innovative RECELL System into the hands of those caring for burn patients across the US.”

The Company is currently putting their tech through its paces in a range of clinical trials and preclinical studies to expand the approved indications for the System. This saw total operating expenses increase 42% to $14.8 million for the December quarter. They remain well funded for these endeavours with $55.5 million in cash and another $49.3 million in short and long-term marketable securities as at December 31st 2021. 

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • In an age where celebs own tequila brands, this one owns a hangover cure - May 18, 2022
  • Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap - May 17, 2022
  • This company is offering DNA tests for the whole family, including the dog! - May 16, 2022
  •  
  •  
  •  
  •  
  • biotech
  • burn scar
  • fiona woo
  • pharmaceuticals
  • recell
  • regenerative treatment
  • spray on skin
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • March 18, 2022, 11:26 am

    […] the pavlova is disputed, we gladly claim awesome inventions like the black box flight recorder, spray-on skin, the cochlear implant, plastic money and fairy bread (arguably the greatest invention of them […]

    Reply
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • In an age where celebs own tequila brands, this one owns a hangover cure - May 18, 2022
  • Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap - May 17, 2022
  • This company is offering DNA tests for the whole family, including the dog! - May 16, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • In an age where celebs own tequila brands, this one owns a hangover cure - May 18, 2022
  • Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap - May 17, 2022
  • This company is offering DNA tests for the whole family, including the dog! - May 16, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

Copyright © 2020 The Sentiment. All rights reserved.